lung cancer

The study found that with use of the mass spec-based test, about a third of surgeries and total invasive procedures, including biopsies, could be avoided.

This story has been updated with comments from outside researchers and clinicians. LC-MS-based proteomics has officially entered the clinic with the launch this week of Integrated Diagnostics' Xpresys Lung test.

Pages